Yolanda Alagón, general manager of Janssen Colombia, discusses the company's footprint in Colombia and Latin America and her strategy for the affiliate moving forward.
You have been appointed General Manager three years ago, becoming one of the first women to lead a pharma company in Latin America. You mentioned your goal is to “contribute to growth that should be driven by better and greater access to pharmacological treatments, to improve the health and quality of life of people.” What steps have you been taking to achieve this goal?
"Oncology is a very important area where we offer medicine for prostate cancer with expectations on launching the new solution in this specific area in the near future."
